Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 2020-03059 | Other Identifier | Ethical permit |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Karolinska University Hospital | OTHER |
Not provided
Not provided
Not provided
Not provided
Every-day life means being part of a complex environment and performing complex tasks that usually involve a combination of motor and cognitive skills. However, the process of aging or the sequelae of neurological diseases such as Multiple Sclerosis (MS) compromises motor-cognitive interaction necessary for an independent lifestyle. While motor-cognitive performance has been identified as an important goal for sustained health across different clinical populations, little is known about underlying brain function leading to these difficulties and how to best target these motor-cognitive difficulties in the context of rehabilitation and exercise interventions.
The challenge of improving treatments of motor-cognitive difficulties (such as dual-tasking and navigation) is daunting, and an important step is arriving at a method that accurately portrays these impairments in an ecological valid state. The investigators aim therefore to explore brain function during complex walking in MS (in comparison with people with Parkinson's disease and healthy controls) by investigating the effects of neurological disease on motor-cognitive performance and its neural correlates during three conditions of complex walking (dual-task walking, navigation and a combination of both) using non-invasive measures of brain activity (functional near infrared spectrometry, fNIRS) and advanced gait analysis in real time in people with MS (in comparison with people with Parkinson's disease and healthy adults).
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Multiple Sclerosis | People with Multiple Sclerosis, 18 years or older |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| No intervention | Other | Assessment of brain activity with fNIRS and behavioural assessments (motor, motor-cognitive and cognitive) during three complex walking conditions.
|
| Measure | Description | Time Frame |
|---|---|---|
| Functional near infrared spectrometry (fNIRS) | The measurement of changes in concentration of HbO and HHb in the prefrontal cortex will be assessed using a NIRSPORT 2 (NIRx Medizintechnik, Berlin, Germany) device. | During the test session during all three conditions |
| Gait performance during all conditions | Gait variables such as stride time and/or velocity will be analyzed with the APDM mobility system. | During the test session during all three conditions |
| Dual-task performance-reaction time | Cognitive performance of the dual task will be assessed as errors in the response to the Auditory stroop task. | During the test session during complex walking condition 1 and 3 |
| Measure | Description | Time Frame |
|---|---|---|
| Cognitive function- composite score | The cognitive test battery comprised the following tests: The Color-Word Interference Test (CWIT), Verbal Fluency, Trail Making Test (TMT) and Ray Auditory Verbal Learning Test (RAVLT) and Symbol Digit Modalities Test (SDMT). Cognitive function will be assessed as a composite measure of these test together. | During the test session, takes about 50 minutes |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
We are studying complex walking in four different populations, people with Multiple Sclerosis, healthy young adults, healthy elderly and elderly with Parkinson's disease. We have during 2022 completed data collection (ClinicalTrials.gov ID: NCT05218213) of healthy young adults, healthy elderly and elderly with Parkinson's disease. Hence, this registration concerns the MS cohort.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Erika Franzén, PhD9 | Karolinska Institutet | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Karolinska Institutet | Stockholm | Solna | 17177 | Sweden |
The datasets generated during and/or analysed during the current study are not publicly available due to Swedish and EU personal data legislation but are available from the principal investigator on reasonable request. Any sharing of data will be regulated via a data transfer and user agreement with the recipient.
We plan to share this when applicable on OSF or similar
The datasets generated during and/or analysed during the current study are not publicly available due to Swedish and EU personal data legislation but are available from the principal investigator on reasonable request. Any sharing of data will be regulated via a data transfer and user agreement with the recipient.
Not provided
Not provided
| ID | Term |
|---|---|
| D009103 | Multiple Sclerosis |
| D020233 | Gait Disorders, Neurologic |
| D009043 | Motor Activity |
| ID | Term |
|---|---|
| D020278 | Demyelinating Autoimmune Diseases, CNS |
| D020274 | Autoimmune Diseases of the Nervous System |
| D009422 | Nervous System Diseases |
| D003711 | Demyelinating Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Cognitive function - verbal fluency | Verbal function, initiation & task-set switching with the Verbal Fluency test from D-KEFS (Delis-Kaplan Executive Function System). | During the test session, takes about 12 minutes |
| Cognitive function - Attention and psychomotor processing speed | Attention and psychomotor processing speed will be assessed with the Trail Making Test (TMT) from D-KEFS (Delis-Kaplan Executive Function System). | During the test session, takes about 3 minutes |
| Cognitive function - Episodic memory | Episodic memory will be assessed with the Ray Auditory Verbal Learning Test (RAVLT). | During the test session, takes about 30 minutes |
| Cognitive function - Cognitive processing speed | Cognitive processing speed will be assessed with the Symbol Digit Modalities Test (SDMT) | During the test session, takes about 3 minutes |
| Cognitive function - Inhibition & task-set switching | Inhibition & task-set switching with the The Color-Word Interference Test (CWIT) from D-KEFS (Delis-Kaplan Executive Function System). | During the test session, takes about 5 minutes |
| Self-reported level of physical activity | Assessed with the Frändin-Grimby Scale (score 1-6, higher score=better) | Will be answered before the test session in the patients home or during the test session |
| Physical activity level and intensity | Assessed with accelerometers (Actigraph GT3X+) | For one week after the test session |
| Overall MS-disability | Assessed with the Expanded Disability Status Scale (EDSS). Higher scores=worse/more severe disability | During the test session |
| Balance performance | Assessed with the Mini-BESTest (Balance Evaluation Systems test), 0-28p. | During the test session |
| Anxiety and depression | Assessed with Hospital Anxiety and Depression Scale (HADS), 0-24 on the depression and anxiety part respectively. Lower score=better | Will be answered before the test session in the patients home or during the test session |
| Walking ability | Self-assessed walking ability with the WALK-12G. | Will be answered before the test session in the patients home or at the test session |
| Dual-task performance -errors | Cognitive performance of the dual task will be assessed as the reaction time to respond during Auditory stroop | During the test session during dual task conditions |
| Disability | WHO Disability Assessment Schedule (WHODAS) version 2.0, 12 self-assessed questions (12 to 60) more points=worse | Will be answered before the test session in the patients home or during the test session |
| Impact of Fatigue | Self-assessed impact of fatigue on physical, cognitive, and psychosocial functioning, with the Modified Fatigue Impact Scale (MFIS). 21 items, scored from 0 to 4. Higher scores indicate a larger impact of fatigue. | Will be answered before the test session in the patients home or during the test session |
| Impact of MS on health | Self-assessed physical and psychological impact of MS on health. 29 items, rated from 1 to 5. Higher score indicates perceived worse physical or psychological impacts of MS, respectively, on health. | Will be answered before the test session in the patients home or during the test session |
| D001327 | Autoimmune Diseases |
| D007154 | Immune System Diseases |
| D009461 | Neurologic Manifestations |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D001519 | Behavior |